Ashwani Verma

Stock Analyst at UBS

(1.6)
# 1723
Out of 5,441 analysts
87
Total ratings
Success rate
Average return
24 Stocks
Name Action PT Current % Upside Ratings Updated
UTHR United Therapeutics
Maintains: Strong Buy
385 415
300.44 38.13% 6 Aug 13, 2025
ACAD ACADIA Pharmaceutica...
Maintains: Strong Buy
32 36
24.83 44.99% 5 Aug 8, 2025
EXEL Exelixis
Maintains: Neutral
43 38
37.43 1.52% 4 Jul 30, 2025
IMVT Immunovant
Maintains: Neutral
17 18
14.76 21.95% 1 Jul 28, 2025
NBIX Neurocrine Bioscienc...
Maintains: Strong Buy
152 174
123.99 40.33% 9 Jul 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 54
36.23 49.05% 3 Jul 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
24 23
16.42 40.07% 9 Jun 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
33 42
26.55 58.19% 5 Jun 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
61 61
79.21 -22.99% 1 Jun 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
47 41
33.2 23.49% 5 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 48
34.83 37.81% 2 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
2 2
0.88 19.32% 5 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
145 179
110.76 61.61% 6 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
22 14
12.79 9.46% 2 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
106 114
69.11 64.95% 2 Dec 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
55 54
13.43 302.08% 3 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
83 79
131.87 -40.09% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
107 105
103.95 1.01% 2 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28
36.2 -22.65% 3 Jun 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
11 7
113.65 -93.84% 1 Aug 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
209
329.83 -36.63% 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
9 12
9.87 21.58% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
0.5 2900% 1 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
137 71
116.3 -38.95% 3 Aug 4, 2022